Back
Sarepta Therapeutics Vs. Catalyst Pharmaceuticals Industry Stock Comparison
Buy
60
SRPT
Sarepta Therapeutics
Last Price:
156.70
Seasonality Move:
18.65%
Buy
56
CPRX
Catalyst Pharmaceuticals
Last Price:
15.76
Seasonality Move:
35.72%
Buy
60
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $156.75. The Score for SRPT is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals a Buy, Sell or Hold?
- The current Catalyst Pharmaceuticals [CPRX] share price is $15.77. The Score for CPRX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- CPRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $156.75
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
CPRX Stock Price Chart
What is Catalyst Pharmaceuticals's stock price today?
-
The Catalyst Pharmaceuticals share price today is $15.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing slight buying pressure.
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.96 | Buy |
| Relative Strength Index (14 RSI): | 67.49 | Buy |
| Chaikin Money Flow: | -725627 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (114.49 - 149.01) | Buy |
| Bollinger Bands (100): | (118.43 - 138.47) | Buy |
CPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 54.32 | Buy |
| Chaikin Money Flow: | 139290 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.17 - 16.05) | Buy |
| Bollinger Bands (100): | (14.56 - 16.34) | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 154.44 | Buy |
| 20-day SMA: | 134.31 | Buy |
| 50-day SMA: | 130.36 | Buy |
| 200-day SMA: | 116.02 | Buy |
| 8-day EMA: | 151.7 | Buy |
| 20-day EMA: | 140.67 | Buy |
| 50-day EMA: | 132.57 | Buy |
| 200-day EMA: | 121.76 | Buy |
CPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.34 | Buy |
| 20-day SMA: | 15.48 | Buy |
| 50-day SMA: | 15.58 | Buy |
| 200-day SMA: | 14.62 | Buy |
| 8-day EMA: | 15.38 | Buy |
| 20-day EMA: | 15.47 | Buy |
| 50-day EMA: | 15.56 | Buy |
| 200-day EMA: | 14.97 | Buy |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.
Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.09 per share, a decrease this year of $0.14 per share, and an increase next year of $0.20 per share.
Sarepta Therapeutics Technical Analysis
| Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Catalyst Pharmaceuticals Technical Analysis
| Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||